{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:44:59Z","timestamp":1790675099360,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.clinbiochem.2021.11.009","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T10:54:19Z","timestamp":1637578459000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Biomarkers of B cell activation in autoimmune connective tissue diseases: More than markers of disease activity"],"prefix":"10.1016","volume":"100","author":[{"given":"Amy X.","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gniadecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2021.11.009_b0005","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.147.9.2902","article-title":"Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease","volume":"147","author":"Lampe","year":"1991","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.11.009_b0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/096120339200100203","article-title":"Autoimmunity, polyclonal B-cell activation and infection","volume":"1","author":"Granholm","year":"1992","journal-title":"Lupus"},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0015","first-page":"3","article-title":"Crossroads of B cell activation in autoimmunity: rationale of targeting B cells","volume":"77","author":"D\u00f6rner","year":"2006","journal-title":"J. Rheumatol. Suppl."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0020","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2147\/DDDT.S139248","article-title":"Current perspective on rituximab in rheumatic diseases","volume":"11","author":"Schioppo","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.11.009_b0025","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/17843286.2018.1521904","article-title":"Rituximab in systemic autoimmune rheumatic diseases: indications and practical use","volume":"74","author":"Berghen","year":"2019","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0030","first-page":"17","article-title":"Biomarkers of diffuse large B-cell lymphoma: impact on diagnosis, treatment, and prognosis","volume":"3","author":"Coutinho","year":"2013","journal-title":"Current Biomarker Findings."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjh.13156","article-title":"Guidelines on the diagnosis and investigation of AL amyloidosis","volume":"168","author":"Gillmore","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.11.009_b0040","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ajh.24756","article-title":"Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease","volume":"92","author":"Mohan","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0045","unstructured":"B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts, P. Walter, B Cells and Antibodies, Garland Science, 2002. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK26884\/ (accessed July 12, 2020)."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0050","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.11.009_b0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.0300-9475.2004.01376.x","article-title":"Immunoglobulin levels amongst persons with and without human immunodeficiency virus type 1 infection in Uganda and Norway","volume":"59","author":"Lugada","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0060","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","article-title":"Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities: Serum immunoglobulin levels in adults","volume":"151","author":"Gonzalez-Quintela","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0065","unstructured":"H.A. Homburger, R.J. Singh, 96 - Assessment of proteins of the immune system, in: R.R. Rich, T.A. Fleisher, W.T. Shearer, H.W. Schroeder, A.J. Frew, C.M. Weyand (Eds.), Clinical Immunology (Third Edition), Mosby, Edinburgh, 2008: pp. 1419\u20131434. 10.1016\/B978-0-323-04404-2.10096-X."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3410\/M5-4","article-title":"Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?","volume":"5","author":"Brebner","year":"2013","journal-title":"F1000 Med Rep."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/CBF.S57681","article-title":"Polyclonal free light chains: promising new biomarkers in inflammatory disease","volume":"4","author":"Hampson","year":"2014","journal-title":"Current Biomarker Findings."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.11.009_b0080","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.autrev.2019.03.003","article-title":"Free light chains and autoimmunity","volume":"18","author":"Napodano","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000096760","article-title":"Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias","author":"Mayo","year":"2006","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fimmu.2016.00388","article-title":"Significant differences in physicochemical properties of human immunoglobulin kappa and lambda CDR3 regions","volume":"7","author":"Townsend","year":"2016","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.11.009_b0095","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1172\/JCI107023","article-title":"The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia","volume":"51","author":"Waldmann","year":"1972","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.11.009_b0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/2040620712466863","article-title":"Serum free light-chain assay for the detection and monitoring of multiple myeloma and related conditions","volume":"4","author":"Tosi","year":"2013","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0105","first-page":"163","article-title":"Beta 2-microglobulin: its significance and clinical usefulness","volume":"20","author":"Bethea","year":"1990","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"Pt 2","key":"10.1016\/j.clinbiochem.2021.11.009_b0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/bj2770359","article-title":"Molecular comparisons of the beta 2-microglobulin-binding site in class I major-histocompatibility-complex alpha-chains and proteins of related sequences","volume":"277","author":"Tysoe-Calnon","year":"1991","journal-title":"Biochem. J."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0115","first-page":"27","article-title":"beta 2-Microglobulin in clinical medicine","volume":"154","author":"Karlsson","year":"1980","journal-title":"Scand. J. Clin. Lab. Invest. Suppl."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.11.009_b0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0377-1237(17)30745-1","article-title":"Clinical utility of beta 2 microglobulin measurement","volume":"53","author":"SHARMA","year":"1997","journal-title":"Armed Forces Med. J. India."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0125","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/ard.2004.030643","article-title":"Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren\u2019s syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2017.04.005","article-title":"Sjogren\u2019s syndrome: Clinical aspects","volume":"182","author":"Vivino","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0135","first-page":"789","article-title":"Nailfold capillaroscopic findings in primary Sjogren\u2019s syndrome: clinical and serological correlations","volume":"23","author":"Capobianco","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12886-017-0412-8","article-title":"Analysis of novel Sjogren\u2019s syndrome autoantibodies in patients with dry eyes","volume":"17","author":"Everett","year":"2017","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/kel270","article-title":"Clinical and immunological characteristics of patients with Sj\u00f6gren\u2019s syndrome in relation to alpha-fodrin antibodies","volume":"46","author":"Willeke","year":"2007","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.11.009_b0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF02214934","article-title":"The diagnosis value of \u03b22-microglobulin and immunoglobulins in primary Sj\u00f6gren\u2019s syndrome","volume":"14","author":"Bongi","year":"1995","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.11.009_b0160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0896-8411(89)90183-2","article-title":"Lacrimal and salivary immunoglobulins in Sj\u00f6gren\u2019s syndrome","volume":"2","author":"Amor","year":"1989","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/cei.13385","article-title":"Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases","volume":"199","author":"Gulli","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059868","article-title":"Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sj\u00f6gren\u2019s syndrome, Data at Enrollment in the Prospective ASSESS Cohort","volume":"8","author":"Gottenberg","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0175","doi-asserted-by":"crossref","unstructured":"K. James, C. Chipeta, A. Parker, S. Harding, S.J. Cockell, C.S. Gillespie, J. Hallinan, F. Barone, S.J. Bowman, W.-F. Ng, B.A. Fisher, UK Primary Sj\u00f6gren\u2019s Syndrome Registry, B-cell activity markers are associated with different disease activity domains in primary Sj\u00f6gren\u2019s syndrome, Rheumatology . 57 (2018) 1222\u20131227. 10.1093\/rheumatology\/key063.","DOI":"10.1093\/rheumatology\/key063"},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0180","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/rheumatology\/key180","article-title":"Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sj\u00f6gren\u2019s syndrome","volume":"57","author":"Verstappen","year":"2018","journal-title":"Rheumatology."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0185","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/1756-185X.12965","article-title":"Diagnostic accuracy of salivary and serum-free light chain assays in primary Sj\u00f6gren\u2019s syndrome: a pilot study","volume":"20","author":"Sandhya","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/ard.45.3.210","article-title":"Urinary monoclonal free light chains in primary Sj\u00f6gren\u2019s syndrome: an aid to the diagnosis of malignant lymphoma","volume":"45","author":"Walters","year":"1986","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0195","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0003-9969(94)90024-8","article-title":"Increased beta 2-microglobulin in both parotid and submandibular\/sublingual saliva from patients with Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Mogi","year":"1994","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0200","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/ard.52.6.461","article-title":"Beta 2 microglobulin measurements in saliva of patients with primary Sj\u00f6gren\u2019s syndrome: influence of flow","volume":"52","author":"van der Geest","year":"1993","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0205","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF02283111","article-title":"The diagnostic value of salivary fluid levels of beta 2-microglobulin, lysozyme and lactoferrin for primary Sj\u00f6gren\u2019s syndrome","volume":"11","author":"Markusse","year":"1992","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF02284053","article-title":"Diagnostic significance of salivary levels of beta 2-microglobulin in Sj\u00f6gren\u2019s syndrome","volume":"7","author":"Swaak","year":"1988","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0215","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1136\/ard.2011.153098","article-title":"Serum 2 microglobulin correlates with the new ESSDAI in patients with Sjogren\u2019s syndrome","volume":"70","author":"Pertovaara","year":"2011","journal-title":"Ann. Rheumat. Dis."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0220","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/03009747809098844","article-title":"Serum beta-2-microglobulin in Sj\u00f6gren\u2019s syndrome","volume":"7","author":"Str\u00f6m","year":"1978","journal-title":"Scand. J. Rheumatol."},{"issue":"24","key":"10.1016\/j.clinbiochem.2021.11.009_b0225","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM197512112932404","article-title":"Beta2 microglobulin and lymphocytic infiltration in Sj\u00f6gren\u2019s syndrome","volume":"293","author":"Michalski","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0230","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/rheumatology\/38.11.1113","article-title":"The occurrence of renal involvement in primary Sj\u00f6gren\u2019s syndrome: a study of 78 patients","volume":"38","author":"Pertovaara","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0235","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","article-title":"Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sj\u00f6gren\u2019s syndrome","volume":"66","author":"Seror","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0240","doi-asserted-by":"crossref","DOI":"10.2174\/157339509787314387","article-title":"A common pathway for all autoimmune diseases? The unholy alliance of environment, cell death and nucleic acids","volume":"5","author":"Hoffmann","year":"2009","journal-title":"Curr. Immunol. Rev."},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.11.009_b0245","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/rheumatology\/ket488","article-title":"A comparison of the outcome of adolescent and adult-onset systemic lupus erythematosus","volume":"53","author":"Amaral","year":"2014","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.clinbiochem.2021.11.009_b0250","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0255","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","article-title":"A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients","volume":"14","author":"Yaniv","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2369-14-63","article-title":"Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis","volume":"14","author":"Tan","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0265","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.imlet.2014.11.001","article-title":"B cell epitope spreading: mechanisms and contribution to autoimmune diseases","volume":"163","author":"Cornaby","year":"2015","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.11.009_b0270","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0275","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jcp.53.6.424","article-title":"The use of laboratory tests in the diagnosis of SLE","volume":"53","author":"Egner","year":"2000","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.11.009_b0280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5152\/eurjrheum.2015.0113","article-title":"Differential diagnosis of elevated erythrocyte sedimentation rate and C-reactive protein levels: a rheumatology perspective","volume":"2","author":"Bitik","year":"2015","journal-title":"Eur. J. Rheumatol. Inflamm."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0285","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/171028","article-title":"IgG, IgM, and IgA antinuclear antibodies in discoid and systemic lupus erythematosus patients","volume":"2014","author":"Jost","year":"2014","journal-title":"ScientificWorldJournal."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071458","article-title":"Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease","volume":"8","author":"Villalta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0295","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1067\/mjd.2002.109251","article-title":"Vesiculobullous systemic lupus erythematosus: a case with circulating IgG and IgA autoantibodies to type VII collagen","volume":"47","author":"Nitta","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0300","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/archinte.1985.00360100105017","article-title":"Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity","volume":"145","author":"Hirohata","year":"1985","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.11.009_b0305","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10067-010-1674-1","article-title":"Normalization of serum-free light chains in patients with systemic lupus erythematosus upon rituximab treatment and correlation with biological disease activity","volume":"30","author":"Chiche","year":"2011","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.11.009_b0310","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10067-019-04827-4","article-title":"Determination of serum free light chains as a marker of systemic lupus flare","volume":"39","author":"Cambr\u00f3n","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138753","article-title":"Elevated concentrations of serum immunoglobulin free light chains in systemic lupus erythematosus patients in relation to disease activity, inflammatory status, B cell activity and Epstein-Barr virus antibodies","volume":"10","author":"Draborg","year":"2015","journal-title":"PLoS One."},{"issue":"9","key":"10.1016\/j.clinbiochem.2021.11.009_b0320","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/0961203314530793","article-title":"Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus","volume":"23","author":"Jolly","year":"2014","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.11.009_b0325","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/acr.20446","article-title":"Serum free light chains as biomarkers for systemic lupus erythematosus disease activity","volume":"63","author":"Aggarwal","year":"2011","journal-title":"Arthritis Care Res."},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.11.009_b0330","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/ard.27.6.537","article-title":"Free immunoglobulin light chains in connective tissue diseases","volume":"27","author":"Cooper","year":"1968","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0335","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF00918666","article-title":"Clinical relapse in systemic lupus erythematosus: correlation with antecedent elevation of urinary free light-chain immunoglobulin","volume":"9","author":"Hopper","year":"1989","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0340","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1006686514743","article-title":"Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig","volume":"20","author":"Hopper","year":"2000","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0345","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1051\/bmdcn\/2019090316","article-title":"Evaluation of the serum \u03b22 Microglobulin level in patients with systemic lupus erythematosus and its correlation with disease activity","volume":"9","author":"Aghdashi","year":"2019","journal-title":"Biomedicine."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.11.009_b0350","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0961203319828822","article-title":"Anti-\u03b1-enolase antibody combined with \u03b22 microglobulin evaluated the incidence of nephritis in systemic lupus erythematosus patients","volume":"28","author":"Huang","year":"2019","journal-title":"Lupus"},{"issue":"14","key":"10.1016\/j.clinbiochem.2021.11.009_b0355","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1177\/0961203314547797","article-title":"Urine \u03b22-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus","volume":"23","author":"Choe","year":"2014","journal-title":"Lupus"},{"issue":"10","key":"10.1016\/j.clinbiochem.2021.11.009_b0360","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1177\/0961203312447668","article-title":"Increased serum \u03b22-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients","volume":"21","author":"Hermansen","year":"2012","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.11.009_b0365","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MAJ.0b013e3181d26dfb","article-title":"Beta2-microglobulin can be a disease activity marker in systemic lupus erythematosus","volume":"339","author":"Kim","year":"2010","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0370","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000045663","article-title":"Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis","volume":"85","author":"Tsai","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0375","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4049\/jimmunol.122.2.614","article-title":"Anti-beta2-microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus","volume":"122","author":"Revillard","year":"1979","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.11.009_b0380","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the sledai. A disease activity index for lupus patients","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheumat."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0385","doi-asserted-by":"crossref","unstructured":"I. \u017bychowska, D. Suszek, M. Dryglewska, M. Majdan, \u03b22-microglobulin as a marker of systemic lupus erythematosus activity, Adv. Clin. Exp. Med. 27 (2018) 379\u2013382. 10.17219\/acem\/68291.","DOI":"10.17219\/acem\/68291"},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0390","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1177\/0961203318784661","article-title":"Plasma levels of \u03b22-microglobulin are associated with atherosclerosis in patients with systemic lupus erythematosus: a cross-sectional cohort study","volume":"27","author":"Leffers","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0395","first-page":"409","article-title":"Dermatomyositis and malignancy","volume":"65","author":"Hu","year":"2019","journal-title":"Can. Fam. Phys."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0400","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1600-0560.1997.tb01458.x","article-title":"The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus","volume":"24","author":"Magro","year":"1997","journal-title":"J. Cutan. Pathol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2021.11.009_b0405","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.autrev.2011.10.024","article-title":"Hematological malignancy associated with polymyositis and dermatomyositis","volume":"11","author":"Marie","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0410","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2007-10-121285","article-title":"Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders","volume":"111","author":"Brown","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0415","article-title":"Multiple myeloma associated with dermatomyositis: a short report and mini-review","volume":"5","author":"Islam","year":"2018","journal-title":"Int. J. Blood Res. Disorders"},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.11.009_b0420","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0049-0172(77)90033-6","article-title":"Acute dermatomyositis-polymyositis and malignancy","volume":"6","author":"Talbott","year":"1977","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.11.009_b0425","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0002-9343(75)90406-4","article-title":"Amyloidosis associated with dermatomyositis and features of multiple myeloma. The progression of amyloidosis associated with corticosteroid and cytotoxic drug therapy","volume":"59","author":"Zilko","year":"1975","journal-title":"Am. J. Med."},{"issue":"10103","key":"10.1016\/j.clinbiochem.2021.11.009_b0430","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0435","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000501591","article-title":"Use of extracorporeal photopheresis in scleroderma: a review","volume":"236","author":"Du","year":"2020","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.11.009_b0440","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jcla.20342","article-title":"IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis","volume":"23","author":"Mart\u00c3\u00adnez-Cordero","year":"2009","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0445","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jclinpath-2017-204656","article-title":"Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu","volume":"71","author":"Bosello","year":"2018","journal-title":"J. Clin. Pathol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2021.11.009_b0450","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.autrev.2014.07.003","article-title":"Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity","volume":"13","author":"Lanteri","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0455","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF02031609","article-title":"Serum beta 2-microglobulin in systemic sclerosis","volume":"4","author":"Pagano","year":"1985","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0460","first-page":"2063","article-title":"Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis","volume":"34","author":"Giusti","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0465","series-title":"Manual of Molecular and Clinical Laboratory Immunology","first-page":"88","article-title":"Immunochemical characterization of immunoglobulins in serum, urine, and cerebrospinal fluid","author":"Katzmann","year":"2006"},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.11.009_b0470","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1164\/rccm.201104-0761OC","article-title":"An association between neutrophils and immunoglobulin free light chains in the pathogenesis of chronic obstructive pulmonary disease","volume":"185","author":"Braber","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.11.009_b0475","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4049\/jimmunol.0901129","article-title":"Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases","volume":"185","author":"Rijnierse","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clinbiochem.2021.11.009_b0480","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4103\/0366-6999.176084","article-title":"The implication and significance of beta 2 microglobulin: a conservative multifunctional regulator","volume":"129","author":"Li","year":"2016","journal-title":"Chin. Med. J."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.11.009_b0485","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ndt\/gfv318","article-title":"\u03b22 microglobulin amyloidosis: an update 30 years later","volume":"31","author":"Jadoul","year":"2016","journal-title":"Nephrol. Dial. Transplant."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021003088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021003088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:58:15Z","timestamp":1757865495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912021003088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":97,"alternative-id":["S0009912021003088"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.11.009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of B cell activation in autoimmune connective tissue diseases: More than markers of disease activity","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}